Results 171 to 180 of about 3,440,903 (289)
Molecular Oncology, EarlyView.Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Multi-modal and multi-agent reinforcement learning framework for urban traffic flow prediction and signal control optimization. [PDF]
Sci RepWang R, Zhang J, Wang X, He H, Zou Y.
europepmc +1 more source
Molecular Oncology, EarlyView.Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Optimized super-twisting active disturbance rejection control based on nonlinear extended state observer for aircraft attitude stabilization. [PDF]
Sci RepYazdiniya F, Ansarifar G.
europepmc +1 more source
The Linear Expenditure System and Demand for Housing under Rent Control
, 1977 Per Högberg, N. Anders Klevmarken
openalex +1 more source
New LMI methods to the robust control of discrete-time Markov jump linear systems
, 2013 Marcos G. Todorov, Marcelo D. Fragoso
openalex +2 more sources
Static state feedback linearization of nonlinear control systems on homogeneous time scales [PDF]
, 2015 Zbigniew Bartosiewicz +3 more
openalex +1 more source
Molecular Oncology, EarlyView.Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source